Catalytic Azide Reduction in Biological Environments

ChemBioChem

Volumn 13, Issue 8, 2012, Pages 1116-1120

  Sasmal, Pijus K ^a   Carregal Romero, Susana ^a   Han, Alice A ^b   Streu, Craig N ^b   Lin, Zhijie ^a   Namikawa, Kazuhiko ^c   Elliott, Samantha L ^b   Köster, Reinhard W ^c   Parak, Wolfgang J ^a   Meggers, Eric ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ST MARY'S COLLEGE OF MARYLAND   (United States)

^c TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Azide reductions; Catalysis; Cellular chemistry; Fluorescence; Iron porphyrins

Indexed keywords

6 TETRAARYLPORPHINE DERIVATIVE; AMINE; AZIDE; CHEMICAL COMPOUND; FLUOROPHORE; IRON; REDUCING AGENT; THIOL DERIVATIVE; UNCLASSIFIED DRUG; WATER;

AIR; ARTICLE; BIOCHEMICAL COMPOSITION; BIOCHEMISTRY; CAENORHABDITIS ELEGANS; CATALYSIS; CATALYST; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REDUCTION; ZEBRA FISH;

AMINES; ANIMALS; AZIDES; CAENORHABDITIS ELEGANS; CATALYSIS; ENVIRONMENT; FERRIC COMPOUNDS; HELA CELLS; HUMANS; METALLOPORPHYRINS; OXIDATION-REDUCTION; ZEBRAFISH;

CAENORHABDITIS ELEGANS; DANIO RERIO; MAMMALIA; NEMATODA;

EID: 84861418856     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.201100719     Document Type: Article

References (47)

1. U. Schatzschneider, N. Metzler-Nolte, Angew. Chem. 2006, 118, 1534-1537; Angew. Chem. Int. Ed. 2006, 45, 1504-1507;
2. T. W. Hambley, Dalton Trans. 2007, 4929-4937;
3. E. J. Merino, A. K. Boal, J. K. Barton, Curr. Opin. Chem. Biol. 2008, 12, 229-237;
4. A. Mukherjee, P. J. Sadler, Wiley Encyclopedia of Chemical Biology, Wiley, Hoboken, 2009, 1-47;
5. C. G. Hartinger, P. J. Dyson, Chem. Soc. Rev. 2009, 38, 391-401;
6. E. Meggers, Chem. Commun. 2009, 1001-1010;
7. E. A. Hillard, G. Jaouen, Organometallics 2011, 30, 20-27;
8. G. Gasser, I. Ott, N. Metzler-Nolte, J. Med. Chem. 2011, 54, 3-25;
9. W.-H. Ang, A. Casini, G. Sava, P. J. Dyson, J. Organomet. Chem. 2011, 696, 989-998.
10. K. L. Haas, K. J. Franz, Chem. Rev. 2009, 109, 4921-4960.
11. J. M. Antos, M. B. Francis, Curr. Opin. Chem. Biol. 2006, 10, 253-262.
12. L. Hocharoen, J. A. Cowan, Chem. Eur. J. 2009, 15, 8670-8676.
13. T. Y. Lee, J. Suh, Chem. Soc. Rev. 2009, 38, 1949-1957.
14. For pioneering work in this direction, see also
15. A. Schepartz, B. Cuenoud, J. Am. Chem. Soc. 1990, 112, 3247-3249;
16. D. Hoyer, H. Cho, P. G. Schultz, J. Am. Chem. Soc. 1990, 112, 3249-3250.
17. R. M. Yusop, A. Unciti-Broceta, E. M. V. Johansson, R. M. Sánchez-Martín, M. Bradley, Nat. Chem. 2011, 3, 239-243.
18. C. Streu, E. Meggers, Angew. Chem. 2006, 118, 5773-5776; Angew. Chem. Int. Ed. 2006, 45, 5645-5648.
19. For recent examples of catalytically active metal complexes in medicinal chemistry see:
20. D. Salvemini, Z.-Q. Wang, J. L. Zweier, A. Samouilov, H. Macarthur, T. P. Misko, M. G. Currie, S. Cuzzocrea, J. A. Sikorski, D. P. Riley, Science 1999, 286, 304-306;
21. S. J. Dougan, A. Habtemariam, S. E. McHale, S. Parsons, P. J. Sadler, Proc. Natl. Acad. Sci. USA 2008, 105, 11628-11633.
22. It is our experience that not the individual components, but rather the combination of thiols, protic solvent and air causes serious problems for most metal-containing catalysts.
23. E. M. Sletten, C. R. Bertozzi, Angew. Chem. 2009, 121, 7108-7133; Angew. Chem. Int. Ed. 2009, 48, 6974-6998.
24. II-catalyzed azide reduction, see: Y. Chen, A. S. Kamlet, J. B. Steinman, D. R. Liu, Nat. Chem. 2011, 3, 146-153.
25. For recent applications based on the reduction of aromatic azides, see:
26. H. Abe, J. Wang, K. Furukawa, K. Oki, M. Uda, S. Tsuneda, Y. Ito, Bioconjugate Chem. 2008, 19, 1219-1226;
27. Z. Pianowski, K. Gorska, L. Oswald, C. A. Merten, N. Winssinger, J. Am. Chem. Soc. 2009, 131, 6492-6497;
28. A. R. Lippert, E. J. New, C. J. Chang, J. Am. Chem. Soc. 2011, 133, 10078-10080;
29. M. Röthlingshöfer, K. Gorska, N. Winssinger, Org. Lett. 2012, 14, 482-485.
30. For the interaction and activation of organic azides by transition metal complexes, see:
31. S. Cenini, E. Gallo, A. Caselli, F. Ragaini, S. Fantauzzi, C. Piangiolino, Coord. Chem. Rev. 2006, 250, 1234-1253;
32. T. G. Driver, Org. Biomol. Chem. 2010, 8, 3831-3846.
33. II-porphyrin-catalyzed nitrene transfer reactions with aromatic azides, the reduction of the azides to their respective amines was reported as a side reaction. For an example, see: F. Ragaini, A. Penoni, E. Gallo, S. Tollari, C. Li Gotti, M. Lapadula, E. Mangioni, S. Cenini, Chem. Eur. J. 2003, 9, 249-259.
34. For an efficient reduction of organic azides with dithiols, see:
35. I. L. Cartwright, D. W. Hutchinson, V. W. Armstrong, Nucleic Acids Res. 1976, 3, 2331-2339;
36. H. Bayley, J. R. Standring, J. R. Knowles, Tetrahedron Lett. 1978, 19, 3633-3634.
37. Aliphatic azides are not reduced under these conditions as has been tested, for example, for 2-phenethylazide.
38. T. Suzuki, T. Ando, K. Tsuchiya, N. Fukazawa, J. Med. Chem. 1999, 42, 3001-3003.
39. E. A. Novikova, L. F. Avramenko, T. F. Grigorenko, I. D. Laznikova, V. G. Syromyatnikov, L. I. Khmil, Russ. J. Org. Chem. 1998, 34, 1762-1767.
40. The better water-soluble poly(ethylene glycol)-functionalized catalyst [Fe(TPPE)Cl] can be used with a reduced DMSO content, although some DMSO is necessary to dissolve the rhodamine bisazide 3 substrate. See the Experimental Section for more details.
41. F. Kamali, A. Gescher, J. A. Slack, Xenobiotica 1988, 18, 1157-1164;
42. D. Nicholls, A. Gescher, R. J. Griffin, Xenobiotica 1991, 21, 935-943.
43. M. Hu, J. Li, S. Q. Yao, Org. Lett. 2008, 10, 5529-5531;
44. S. W. Kwok, J. R. Fotsing, R. J. Fraser, V. O. Rodionov, V. V. Fokin, Org. Lett. 2010, 12, 4217-4219;
45. P. S. Branco, A. M. M. Antunes, M. M. Marques, M. P. Chiarelli, A. M. Lobo, S. Prabhakar, Chem. Res. Toxicol. 1999, 12, 1223-1233.
46. J. W. Long, I. K. Kim, R. W. Murray, J. Am. Chem. Soc. 1997, 119, 11510-11515.
47. L. L. Del Mercato, A. Z. Abbasi, W. J. Parak, Small 2011, 7, 351-363.